You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pharmacologic Trabeculocanalotomy

Facilitating Aqueous Outflow by Assaulting the Meshwork Cytoskeleton, Junctional Complexes, and Extracellular Matrix

Paul L. Kaufman, MD

Arch Ophthalmol. 1992;110(1):34-36.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The report by Liang et al1 in this issue is significant for two reasons. It illustrates the power of the isolated preparation of organ-cultured human anterior ocular segment in identifying and studying the mechanism of action of potential new antiglaucoma pharmacologic agents. Such studies are usually performed initially in subprimate mammals, then in subhuman primates, and finally in the living human eye. While animal studies are useful, the physiologic and anatomic characteristics of subprimate mammals are often sufficiently different from those of humans to make extrapolation difficult. Primate studies are more relevant, but far more costly and difficult. With increasing concern over the use of animals, especially primates, in biomedical research, these studies have become even more difficult and expensive, threatening the efficient and costeffective development of new antiglaucoma medications. The advent of cell culture technology has brought some relief by allowing study of the effects of pharmacologic agents . . . [Full Text PDF of this Article]


Author Affiliations

Madison, Wis



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.